Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2020-06-23
DOI
10.1080/21678421.2020.1771734
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
- (2019) Ruben P.A. van Eijk et al. NEUROLOGY
- Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015
- (2019) Jaime Raymond et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Riluzole and other prognostic factors in ALS: a population-based registry study in Italy
- (2018) Jessica Mandrioli et al. JOURNAL OF NEUROLOGY
- Riluzole, disease stage and survival in ALS
- (2018) Thanuja Dharmadasa et al. LANCET NEUROLOGY
- Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
- (2018) Ton Fang et al. LANCET NEUROLOGY
- TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole
- (2018) Moritz Oberstadt et al. Scientific Reports
- Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
- (2018) Xueping Chen et al. Frontiers in Neurology
- Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
- (2018) Manoj Kumar Jaiswal MEDICINAL RESEARCH REVIEWS
- Riluzole attenuates the efficacy of glutamatergic transmission by interfering with the size of the readily releasable neurotransmitter pool
- (2018) Vesna Lazarevic et al. NEUROPHARMACOLOGY
- Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection
- (2016) H Blasco et al. EXPERT OPINION ON PHARMACOTHERAPY
- Factors predicting survival in ALS: a multicenter Italian study
- (2016) Andrea Calvo et al. JOURNAL OF NEUROLOGY
- Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China
- (2016) Lu Chen et al. Frontiers in Aging Neuroscience
- Prognostic factors and survival of ALS patients from Belgrade, Serbia
- (2016) Zorica Stevic et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course
- (2015) Hakan Cetin et al. NEUROEPIDEMIOLOGY
- Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010
- (2013) James Rooney et al. PLoS One
- The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy
- (2013) Eleni Georgoulopoulou et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis
- (2012) John A Morren et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan
- (2012) Charles Tzu-Chi Lee et al. JOURNAL OF EPIDEMIOLOGY
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force
- (2011) et al. EUROPEAN JOURNAL OF NEUROLOGY
- Inhibition of Nav 4 Peptide-Mediated Resurgent Sodium Currents in Nav1.7 Channels by Carbamazepine, Riluzole, and Anandamide
- (2011) J. W. Theile et al. MOLECULAR PHARMACOLOGY
- The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
- (2010) Ettore Beghi et al. Amyotrophic Lateral Sclerosis
- A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?
- (2010) Mark C. Bellingham CNS Neuroscience & Therapeutics
- Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
- (2010) B.C. Cheah et al. CURRENT MEDICINAL CHEMISTRY
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
- (2009) R. G. Miller et al. NEUROLOGY
- Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
- (2007) Elena Fumagalli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now